300294SZSE

Special Verification Opinion on the Storage and Use of Funds Raised by China Citic Securities Co., Ltd. for 2025

✨ AI Summary

This report provides a verification opinion on the storage and use of funds raised by China Citic Securities for Huaren Boya Biopharmaceutical Group Co., Ltd. in 2025. A total of RMB 314,601,963.84 was used in 2025, with a cumulative usage of RMB 499,069,217.81. As of December 31, 2025, the remaining balance in the special fund account was RMB 28,783,009.95. The report concludes that the fund management complies with relevant regulations and there are no violations in fund usage.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Special Verification Opinion on the Storage and Use of Funds Raised by China Citic Securities Co., Ltd. for 2025

According to the "Shenzhen Stock Exchange Growth Enterprise Market Listing Rules" (hereinafter referred to as "Listing Rules") and the "Shenzhen Stock Exchange Listed Companies Self-Regulatory Guidelines No. 2 - Standard Operation of Growth Enterprise Market Listed Companies" (hereinafter referred to as "Standard Operation Guidelines"), China Citic Securities Co., Ltd. (hereinafter referred to as "Citic Securities" or "Sponsor") has conducted a verification of the storage and use of funds raised by Huaren Boya Biopharmaceutical Group Co., Ltd. (hereinafter referred to as "Boya Biopharma" or "Company") for the year 2025. The specific situation is as follows:

1. Funds Raised from Non-Public Issuance in 2018

(1) Amount of Funds Raised and Actual Receipt Time

According to the resolution of the Company's second extraordinary general meeting in 2017 and the China Securities Regulatory Commission's approval of the non-public issuance of shares by Boya Biopharma (Zheng Jian Xu Ke [2018] No. 117), the Company was approved to issue no more than 37.5 million shares. On April 4, 2018, Boya Biopharma completed this non-public issuance, issuing a total of 32,247,662 shares at an issue price of RMB 31.01 per share. The Company received a total of RMB 999,999,998.62 from Changcheng Securities Co., Ltd. after deducting underwriting and sponsorship fees of RMB 8,500,000.00, resulting in a net amount of RMB 991,499,998.62. Of this, RMB 791,499,998.62 was deposited in the bank account at Citic Bank Co., Ltd. Nanchang Branch (Account No.: 8115701013100148137), and RMB 200,000,000.00 was deposited in the bank account at Industrial and Commercial Bank of China Co., Ltd. Fuzhou Branch (Account No.: 1511200929100050264). After deducting previously paid and unpaid issuance costs of RMB 2,244,000.00, the actual net amount of funds raised from the non-public issuance was RMB 989,255,998.62. The above-mentioned funds have been verified by Jiangsu Notary Tianye Accounting Firm (Special General Partnership), which issued Verification Report No. Su Gong W[2018]B041.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.